An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans
This study examined whether an immunohistochemical method examining the subcellular localization of STAT5 could be used to characterize the activation of the JAK2/STAT5 pathway by prolactin (PRL) in intact cells or tissues. In the Ins-1 β-cell line, STAT5A and STAT5B were distributed almost equally...
Gespeichert in:
Veröffentlicht in: | The journal of histochemistry and cytochemistry 2002-03, Vol.50 (3), p.365-383 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 383 |
---|---|
container_issue | 3 |
container_start_page | 365 |
container_title | The journal of histochemistry and cytochemistry |
container_volume | 50 |
creator | Brelje, T. Clark Svensson, Annika M Stout, Laurence E Bhagroo, Nicholas V Sorenson, Robert L |
description | This study examined whether an immunohistochemical method examining the subcellular localization of STAT5 could be used to characterize the activation of the JAK2/STAT5 pathway by prolactin (PRL) in intact cells or tissues. In the Ins-1 β-cell line, STAT5A and STAT5B were distributed almost equally in the cytoplasm and the nucleus in unstimulated cells. STAT5A was also detected along the border of cells and in the perinuclear region. After exposure to PRL, the redistribution from the cytoplasm to the nucleus was much higher for STAT5B compared to STAT5A. This translocation represented 12% of the STAT5A and 22% of the STAT5B originally located in the cytoplasm before stimulation. In isolated rat islets of Langerhans, PRL stimulated the nuclear translocation of both STAT5A and STAT5B only in β-cells. The expression of the PRL receptor only by β-cells was confirmed with a rabbit polyclonal antiserum raised against the rat PRL receptor. It was estimated that 4% of STAT5A and 9% of STAT5B originally located in the cytoplasm was translocated to the nucleus after stimulation. The presence of a functional JAK2/STAT5 signaling pathway in all islet cells was demonstrated by the nuclear translocation of STAT5B in all islet cells (i.e., α-, β-, and δ-cells) after stimulation with fetal calf serum. The nuclear translocation and tyrosine phosphorylation of STAT5B was biphasic, with an initial peak within 30 min, a nadir between 1 and 3 hr, and prolonged activation after 4 hr. In contrast, the tyrosine phosphorylation of STAT5A was also biphasic but its nuclear translocation peaked within 30 min and was then reduced to a level slightly above that observed before PRL stimulation. This method is able to detect changes in STAT5 activation as small as 2% of the total cell content. These observations demonstrate the utility of this approach for studying the activation of STAT5 in a mixed population of cells within tissues or organs. In addition, the dose response for the nuclear translocation of STAT5B in normal β-cells was similar to those for changes in proliferation and insulin secretion in isolated rat islets. Therefore, the subcellular localization can be used to monitor the activation of STAT5 and it may be a key event in the upregulation of the pancreatic islets of Langerhans during pregnancy. |
doi_str_mv | 10.1177/002215540205000308 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71456005</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_002215540205000308</sage_id><sourcerecordid>71456005</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-a7c0bfc077b8a81ac46ffb55cf4f87db223eeff5fcc2d45e8707e4c60ac6990c3</originalsourceid><addsrcrecordid>eNp9kM2O0zAUhS0EYjoDL8ACeQO70OvEjtNlNAKmUMRIlLXlOHbjUWIX2yGaN-CxcWklFkis7o--c67uQegVgXeEcL4GKEvCGIUSGABU0DxBq7wgBQNKn6LVCShOxBW6jvEBgFDKmufoipAmI9VmhX61Dm-naXZ-sDF5NejJKjni9ngMXqoBJ4-_eGeTDzgNGt8HP0qVrCus62ele9zm6adM1jvszR_mU_u5XH_bt3uG72UaFvmIrcutU0FnUOFtHHWKJ3wn3UGHQbr4Aj0zcoz65aXeoO8f3u9v74rd14_b23ZXKMo3qZBcQWcUcN41siFS0dqYjjFlqGl435VlpbUxzChV9pTphgPXVNUgVb3ZgKpu0Nuzb_7vx6xjEpONSo-jdNrPUXBCWQ3AMlieQRV8jEEbcQx2kuFREBCn_MW_-WfR64v73E26_yu5BJ6B9RmI8qDFg5-Dy9_-3_LNWTHYw7DYoEWc5DjmA0Qsy8JAVKKqWfUb4E6cHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71456005</pqid></control><display><type>article</type><title>An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SAGE Complete</source><source>Free Full-Text Journals in Chemistry</source><creator>Brelje, T. Clark ; Svensson, Annika M ; Stout, Laurence E ; Bhagroo, Nicholas V ; Sorenson, Robert L</creator><creatorcontrib>Brelje, T. Clark ; Svensson, Annika M ; Stout, Laurence E ; Bhagroo, Nicholas V ; Sorenson, Robert L</creatorcontrib><description>This study examined whether an immunohistochemical method examining the subcellular localization of STAT5 could be used to characterize the activation of the JAK2/STAT5 pathway by prolactin (PRL) in intact cells or tissues. In the Ins-1 β-cell line, STAT5A and STAT5B were distributed almost equally in the cytoplasm and the nucleus in unstimulated cells. STAT5A was also detected along the border of cells and in the perinuclear region. After exposure to PRL, the redistribution from the cytoplasm to the nucleus was much higher for STAT5B compared to STAT5A. This translocation represented 12% of the STAT5A and 22% of the STAT5B originally located in the cytoplasm before stimulation. In isolated rat islets of Langerhans, PRL stimulated the nuclear translocation of both STAT5A and STAT5B only in β-cells. The expression of the PRL receptor only by β-cells was confirmed with a rabbit polyclonal antiserum raised against the rat PRL receptor. It was estimated that 4% of STAT5A and 9% of STAT5B originally located in the cytoplasm was translocated to the nucleus after stimulation. The presence of a functional JAK2/STAT5 signaling pathway in all islet cells was demonstrated by the nuclear translocation of STAT5B in all islet cells (i.e., α-, β-, and δ-cells) after stimulation with fetal calf serum. The nuclear translocation and tyrosine phosphorylation of STAT5B was biphasic, with an initial peak within 30 min, a nadir between 1 and 3 hr, and prolonged activation after 4 hr. In contrast, the tyrosine phosphorylation of STAT5A was also biphasic but its nuclear translocation peaked within 30 min and was then reduced to a level slightly above that observed before PRL stimulation. This method is able to detect changes in STAT5 activation as small as 2% of the total cell content. These observations demonstrate the utility of this approach for studying the activation of STAT5 in a mixed population of cells within tissues or organs. In addition, the dose response for the nuclear translocation of STAT5B in normal β-cells was similar to those for changes in proliferation and insulin secretion in isolated rat islets. Therefore, the subcellular localization can be used to monitor the activation of STAT5 and it may be a key event in the upregulation of the pancreatic islets of Langerhans during pregnancy.</description><identifier>ISSN: 0022-1554</identifier><identifier>EISSN: 1551-5044</identifier><identifier>DOI: 10.1177/002215540205000308</identifier><identifier>PMID: 11850439</identifier><language>eng</language><publisher>Los Angeles, CA: Histochemical Soc</publisher><subject>Animals ; Biological Transport - drug effects ; Blotting, Western ; Cell Nucleus - metabolism ; Cytoplasm - metabolism ; DNA-Binding Proteins - analysis ; DNA-Binding Proteins - metabolism ; Enzyme Activation - drug effects ; Glucagon - analysis ; Immunohistochemistry ; Insulin - analysis ; Insulinoma ; Islets of Langerhans - chemistry ; Islets of Langerhans - metabolism ; Islets of Langerhans - ultrastructure ; Janus Kinase 2 ; Microscopy, Confocal ; Milk Proteins ; Pancreatic Neoplasms ; Phosphorylation ; Phosphotyrosine - metabolism ; Prolactin - pharmacology ; Protein-Tyrosine Kinases - metabolism ; Proto-Oncogene Proteins ; Rats ; Receptors, Prolactin - analysis ; Somatostatin - analysis ; STAT5 Transcription Factor ; Trans-Activators - analysis ; Trans-Activators - metabolism ; Tumor Cells, Cultured</subject><ispartof>The journal of histochemistry and cytochemistry, 2002-03, Vol.50 (3), p.365-383</ispartof><rights>2002 Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-a7c0bfc077b8a81ac46ffb55cf4f87db223eeff5fcc2d45e8707e4c60ac6990c3</citedby><cites>FETCH-LOGICAL-c479t-a7c0bfc077b8a81ac46ffb55cf4f87db223eeff5fcc2d45e8707e4c60ac6990c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/002215540205000308$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/002215540205000308$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11850439$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brelje, T. Clark</creatorcontrib><creatorcontrib>Svensson, Annika M</creatorcontrib><creatorcontrib>Stout, Laurence E</creatorcontrib><creatorcontrib>Bhagroo, Nicholas V</creatorcontrib><creatorcontrib>Sorenson, Robert L</creatorcontrib><title>An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans</title><title>The journal of histochemistry and cytochemistry</title><addtitle>J Histochem Cytochem</addtitle><description>This study examined whether an immunohistochemical method examining the subcellular localization of STAT5 could be used to characterize the activation of the JAK2/STAT5 pathway by prolactin (PRL) in intact cells or tissues. In the Ins-1 β-cell line, STAT5A and STAT5B were distributed almost equally in the cytoplasm and the nucleus in unstimulated cells. STAT5A was also detected along the border of cells and in the perinuclear region. After exposure to PRL, the redistribution from the cytoplasm to the nucleus was much higher for STAT5B compared to STAT5A. This translocation represented 12% of the STAT5A and 22% of the STAT5B originally located in the cytoplasm before stimulation. In isolated rat islets of Langerhans, PRL stimulated the nuclear translocation of both STAT5A and STAT5B only in β-cells. The expression of the PRL receptor only by β-cells was confirmed with a rabbit polyclonal antiserum raised against the rat PRL receptor. It was estimated that 4% of STAT5A and 9% of STAT5B originally located in the cytoplasm was translocated to the nucleus after stimulation. The presence of a functional JAK2/STAT5 signaling pathway in all islet cells was demonstrated by the nuclear translocation of STAT5B in all islet cells (i.e., α-, β-, and δ-cells) after stimulation with fetal calf serum. The nuclear translocation and tyrosine phosphorylation of STAT5B was biphasic, with an initial peak within 30 min, a nadir between 1 and 3 hr, and prolonged activation after 4 hr. In contrast, the tyrosine phosphorylation of STAT5A was also biphasic but its nuclear translocation peaked within 30 min and was then reduced to a level slightly above that observed before PRL stimulation. This method is able to detect changes in STAT5 activation as small as 2% of the total cell content. These observations demonstrate the utility of this approach for studying the activation of STAT5 in a mixed population of cells within tissues or organs. In addition, the dose response for the nuclear translocation of STAT5B in normal β-cells was similar to those for changes in proliferation and insulin secretion in isolated rat islets. Therefore, the subcellular localization can be used to monitor the activation of STAT5 and it may be a key event in the upregulation of the pancreatic islets of Langerhans during pregnancy.</description><subject>Animals</subject><subject>Biological Transport - drug effects</subject><subject>Blotting, Western</subject><subject>Cell Nucleus - metabolism</subject><subject>Cytoplasm - metabolism</subject><subject>DNA-Binding Proteins - analysis</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Enzyme Activation - drug effects</subject><subject>Glucagon - analysis</subject><subject>Immunohistochemistry</subject><subject>Insulin - analysis</subject><subject>Insulinoma</subject><subject>Islets of Langerhans - chemistry</subject><subject>Islets of Langerhans - metabolism</subject><subject>Islets of Langerhans - ultrastructure</subject><subject>Janus Kinase 2</subject><subject>Microscopy, Confocal</subject><subject>Milk Proteins</subject><subject>Pancreatic Neoplasms</subject><subject>Phosphorylation</subject><subject>Phosphotyrosine - metabolism</subject><subject>Prolactin - pharmacology</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>Proto-Oncogene Proteins</subject><subject>Rats</subject><subject>Receptors, Prolactin - analysis</subject><subject>Somatostatin - analysis</subject><subject>STAT5 Transcription Factor</subject><subject>Trans-Activators - analysis</subject><subject>Trans-Activators - metabolism</subject><subject>Tumor Cells, Cultured</subject><issn>0022-1554</issn><issn>1551-5044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM2O0zAUhS0EYjoDL8ACeQO70OvEjtNlNAKmUMRIlLXlOHbjUWIX2yGaN-CxcWklFkis7o--c67uQegVgXeEcL4GKEvCGIUSGABU0DxBq7wgBQNKn6LVCShOxBW6jvEBgFDKmufoipAmI9VmhX61Dm-naXZ-sDF5NejJKjni9ngMXqoBJ4-_eGeTDzgNGt8HP0qVrCus62ele9zm6adM1jvszR_mU_u5XH_bt3uG72UaFvmIrcutU0FnUOFtHHWKJ3wn3UGHQbr4Aj0zcoz65aXeoO8f3u9v74rd14_b23ZXKMo3qZBcQWcUcN41siFS0dqYjjFlqGl435VlpbUxzChV9pTphgPXVNUgVb3ZgKpu0Nuzb_7vx6xjEpONSo-jdNrPUXBCWQ3AMlieQRV8jEEbcQx2kuFREBCn_MW_-WfR64v73E26_yu5BJ6B9RmI8qDFg5-Dy9_-3_LNWTHYw7DYoEWc5DjmA0Qsy8JAVKKqWfUb4E6cHg</recordid><startdate>20020301</startdate><enddate>20020301</enddate><creator>Brelje, T. Clark</creator><creator>Svensson, Annika M</creator><creator>Stout, Laurence E</creator><creator>Bhagroo, Nicholas V</creator><creator>Sorenson, Robert L</creator><general>Histochemical Soc</general><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020301</creationdate><title>An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans</title><author>Brelje, T. Clark ; Svensson, Annika M ; Stout, Laurence E ; Bhagroo, Nicholas V ; Sorenson, Robert L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-a7c0bfc077b8a81ac46ffb55cf4f87db223eeff5fcc2d45e8707e4c60ac6990c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Biological Transport - drug effects</topic><topic>Blotting, Western</topic><topic>Cell Nucleus - metabolism</topic><topic>Cytoplasm - metabolism</topic><topic>DNA-Binding Proteins - analysis</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Enzyme Activation - drug effects</topic><topic>Glucagon - analysis</topic><topic>Immunohistochemistry</topic><topic>Insulin - analysis</topic><topic>Insulinoma</topic><topic>Islets of Langerhans - chemistry</topic><topic>Islets of Langerhans - metabolism</topic><topic>Islets of Langerhans - ultrastructure</topic><topic>Janus Kinase 2</topic><topic>Microscopy, Confocal</topic><topic>Milk Proteins</topic><topic>Pancreatic Neoplasms</topic><topic>Phosphorylation</topic><topic>Phosphotyrosine - metabolism</topic><topic>Prolactin - pharmacology</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>Proto-Oncogene Proteins</topic><topic>Rats</topic><topic>Receptors, Prolactin - analysis</topic><topic>Somatostatin - analysis</topic><topic>STAT5 Transcription Factor</topic><topic>Trans-Activators - analysis</topic><topic>Trans-Activators - metabolism</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brelje, T. Clark</creatorcontrib><creatorcontrib>Svensson, Annika M</creatorcontrib><creatorcontrib>Stout, Laurence E</creatorcontrib><creatorcontrib>Bhagroo, Nicholas V</creatorcontrib><creatorcontrib>Sorenson, Robert L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of histochemistry and cytochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brelje, T. Clark</au><au>Svensson, Annika M</au><au>Stout, Laurence E</au><au>Bhagroo, Nicholas V</au><au>Sorenson, Robert L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans</atitle><jtitle>The journal of histochemistry and cytochemistry</jtitle><addtitle>J Histochem Cytochem</addtitle><date>2002-03-01</date><risdate>2002</risdate><volume>50</volume><issue>3</issue><spage>365</spage><epage>383</epage><pages>365-383</pages><issn>0022-1554</issn><eissn>1551-5044</eissn><abstract>This study examined whether an immunohistochemical method examining the subcellular localization of STAT5 could be used to characterize the activation of the JAK2/STAT5 pathway by prolactin (PRL) in intact cells or tissues. In the Ins-1 β-cell line, STAT5A and STAT5B were distributed almost equally in the cytoplasm and the nucleus in unstimulated cells. STAT5A was also detected along the border of cells and in the perinuclear region. After exposure to PRL, the redistribution from the cytoplasm to the nucleus was much higher for STAT5B compared to STAT5A. This translocation represented 12% of the STAT5A and 22% of the STAT5B originally located in the cytoplasm before stimulation. In isolated rat islets of Langerhans, PRL stimulated the nuclear translocation of both STAT5A and STAT5B only in β-cells. The expression of the PRL receptor only by β-cells was confirmed with a rabbit polyclonal antiserum raised against the rat PRL receptor. It was estimated that 4% of STAT5A and 9% of STAT5B originally located in the cytoplasm was translocated to the nucleus after stimulation. The presence of a functional JAK2/STAT5 signaling pathway in all islet cells was demonstrated by the nuclear translocation of STAT5B in all islet cells (i.e., α-, β-, and δ-cells) after stimulation with fetal calf serum. The nuclear translocation and tyrosine phosphorylation of STAT5B was biphasic, with an initial peak within 30 min, a nadir between 1 and 3 hr, and prolonged activation after 4 hr. In contrast, the tyrosine phosphorylation of STAT5A was also biphasic but its nuclear translocation peaked within 30 min and was then reduced to a level slightly above that observed before PRL stimulation. This method is able to detect changes in STAT5 activation as small as 2% of the total cell content. These observations demonstrate the utility of this approach for studying the activation of STAT5 in a mixed population of cells within tissues or organs. In addition, the dose response for the nuclear translocation of STAT5B in normal β-cells was similar to those for changes in proliferation and insulin secretion in isolated rat islets. Therefore, the subcellular localization can be used to monitor the activation of STAT5 and it may be a key event in the upregulation of the pancreatic islets of Langerhans during pregnancy.</abstract><cop>Los Angeles, CA</cop><pub>Histochemical Soc</pub><pmid>11850439</pmid><doi>10.1177/002215540205000308</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1554 |
ispartof | The journal of histochemistry and cytochemistry, 2002-03, Vol.50 (3), p.365-383 |
issn | 0022-1554 1551-5044 |
language | eng |
recordid | cdi_proquest_miscellaneous_71456005 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SAGE Complete; Free Full-Text Journals in Chemistry |
subjects | Animals Biological Transport - drug effects Blotting, Western Cell Nucleus - metabolism Cytoplasm - metabolism DNA-Binding Proteins - analysis DNA-Binding Proteins - metabolism Enzyme Activation - drug effects Glucagon - analysis Immunohistochemistry Insulin - analysis Insulinoma Islets of Langerhans - chemistry Islets of Langerhans - metabolism Islets of Langerhans - ultrastructure Janus Kinase 2 Microscopy, Confocal Milk Proteins Pancreatic Neoplasms Phosphorylation Phosphotyrosine - metabolism Prolactin - pharmacology Protein-Tyrosine Kinases - metabolism Proto-Oncogene Proteins Rats Receptors, Prolactin - analysis Somatostatin - analysis STAT5 Transcription Factor Trans-Activators - analysis Trans-Activators - metabolism Tumor Cells, Cultured |
title | An Immunohistochemical Approach to Monitor the Prolactin-induced Activation of the JAK2/STAT5 Pathway in Pancreatic Islets of Langerhans |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A45%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20Immunohistochemical%20Approach%20to%20Monitor%20the%20Prolactin-induced%20Activation%20of%20the%20JAK2/STAT5%20Pathway%20in%20Pancreatic%20Islets%20of%20Langerhans&rft.jtitle=The%20journal%20of%20histochemistry%20and%20cytochemistry&rft.au=Brelje,%20T.%20Clark&rft.date=2002-03-01&rft.volume=50&rft.issue=3&rft.spage=365&rft.epage=383&rft.pages=365-383&rft.issn=0022-1554&rft.eissn=1551-5044&rft_id=info:doi/10.1177/002215540205000308&rft_dat=%3Cproquest_cross%3E71456005%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71456005&rft_id=info:pmid/11850439&rft_sage_id=10.1177_002215540205000308&rfr_iscdi=true |